Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4
Alaaeldin Abdelsalam Dawood (Dawood AA), Mohamed Zakarya Nooh (Nooh MZ), Ayman Abdelhaleem Elgamal (Elgamal AA)
Diabetes Metab J. 2017;41(4):316-321.   Published online 2017 Aug 22     DOI: https://doi.org/10.4093/dmj.2017.41.4.316
Citations to this article as recorded by Crossref logo
Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)
Yu Zhou, Wenhuo Xie, Chenhua Zheng, Libin Liu, Zhou Chen, Xiaolu Wang
Clinical Endocrinology.2022; 96(5): 690.     CrossRef
Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González
World Journal of Hepatology.2022; 14(1): 62.     CrossRef
Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
Biomedicines.2022; 10(3): 534.     CrossRef
Hépatite B et C: une mise à jour sur lʼhépatite virale chronique
Marie Ongaro, Francesco Negro
Schweizer Gastroenterologie.2022; 3(1): 19.     CrossRef
Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
Mohamed El-Kassas, Runia El-Folly, Maram Aboromia, Heba Aly, Mohamed Bahgat, Mostafa Hamed
Egyptian Liver Journal.2022;[Epub]     CrossRef
Hepatitis C virus infection and diabetes: A complex bidirectional relationship
Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin
Diabetes Research and Clinical Practice.2022; 187: 109870.     CrossRef
Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?
Rasha Youssef Hagag, Ahmed Fawzy Selim, Omneya Darrag, Hassan Zied, Mohamed Sabry Aboelnasr
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1261.     CrossRef
Global longitudinal strain as a predictor of short-term effect of oral antiviral regimens on myocardium in Egyptian patients with chronic viral hepatitis C
Hazem Mohammad-Ali Farrag, Mina Samir Monir, Wael Soliman Abdel-Dayem, Hisham Abdel-Haleem Ali, Alaa Mohammad Ibrahim
The Egyptian Heart Journal.2021;[Epub]     CrossRef
Residual risk of liver disease after hepatitis C virus eradication
Francesco Negro
Journal of Hepatology.2021; 74(4): 952.     CrossRef
Extrahepatic Manifestations of Chronic HCV Infection
Dan L. Longo, Patrice Cacoub, David Saadoun
New England Journal of Medicine.2021; 384(11): 1038.     CrossRef
Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa
Frontiers in Medicine.2021;[Epub]     CrossRef
Current situation of viral hepatitis in Egypt
Ashraf Elbahrawy, Marwa K. Ibrahim, Ahmed Eliwa, Mohamed Alboraie, Ali Madian, Hussein Hassan Aly
Microbiology and Immunology.2021; 65(9): 352.     CrossRef
The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C
Marco SACCO, Giorgio M. SARACCO
Minerva Gastroenterology.2021;[Epub]     CrossRef
The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection
Basant Mahmoud, Adel Abdel Moneim, Doaa Mabrouk
Clinical and Experimental Medicine.2021;[Epub]     CrossRef
Systematic review: chronic viral hepatitis and metabolic derangement
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao
Alimentary Pharmacology & Therapeutics.2020; 51(2): 216.     CrossRef
Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4
Hassan Yousef Zied, Nashwa Mohamed Abo Alnasr, Amal Said El-Bendary, Sherief Abd-Elsalam, Rasha Youssef Hagag
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(4): 679.     CrossRef
Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
Pradeep Kumar Mada, Matthew E. Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J. Alam, Mark Feldman, John William King
International Journal of Hepatology.2020; 2020: 1.     CrossRef
Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
Clinical Science.2020; 134(16): 2117.     CrossRef
Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control
Jennifer Andres, Michael Barros, Michael Arutunian, Huaqing Zhao
Journal of Managed Care & Specialty Pharmacy.2020; 26(6): 775.     CrossRef
Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
Francesco Negro
Cold Spring Harbor Perspectives in Medicine.2020; 10(4): a036921.     CrossRef
The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm
Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco
Journal of Clinical Medicine.2020; 9(2): 563.     CrossRef
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi
JGH Open.2020; 4(4): 713.     CrossRef
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed
Egyptian Liver Journal.2020;[Epub]     CrossRef
Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert
Indian Journal of Medical Research.2020; 152(6): 562.     CrossRef
Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana
Revista Colombiana de Gastroenterología.2019; 34(3): 277.     CrossRef
Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients
Giacomo Gastaldi, Diana Gomes, Philippe Schneiter, Xavier Montet, Luc Tappy, Sophie Clément, Francesco Negro, Jee-Fu Huang
PLOS ONE.2019; 14(6): e0217751.     CrossRef
The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina
Acta Diabetologica.2019; 56(3): 341.     CrossRef
Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy
Amir Gilad, Zachary P. Fricker, Adam Hsieh, Dylan D. Thomas, Toni Zahorian, David P. Nunes
Journal of Clinical Gastroenterology.2019; 53(8): 616.     CrossRef
Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
Teegan R. Lim, Jonathan M. Hazlehurst, Andrei I. Oprescu, Matthew J. Armstrong, Sewa F. Abdullah, Nigel P. Davies, Robert Flintham, Peter Balfe, David J. Mutimer, Jane A. McKeating, Jeremy W. Tomlinson
Clinical Endocrinology.2019; 90(3): 440.     CrossRef
Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis
Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio
Journal of Viral Hepatitis.2019; 26(11): 1249.     CrossRef
Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska
Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease
Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis
Journal of Viral Hepatitis.2018; 25: 6.     CrossRef
Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series
Braira Wahid, Muhammad Wasim, Komal Saleem, Muhammad Waqar, Khansa Wahid, Manzoor Hussain, Muhammad Idrees
Future Virology.2018; 13(8): 525.     CrossRef
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
A. Provoost, M. Dramé, L. Cotte, L. Cuzin, R. Garraffo, D. Rey, F. Raffi, I. Poizot-Martin, P. Pugliese, F. Bani-Sadr
Alimentary Pharmacology & Therapeutics.2018; 48(3): 281.     CrossRef
The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Mauro Giordano
Expert Review of Anti-infective Therapy.2018; 16(8): 595.     CrossRef
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasov
Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES
Vanessa Gutierrez de ANDRADE, Fábio da Silva YAMASHIRO, Cássio Vieira OLIVEIRA, Alecsandro MOREIRA, Fernanda Cristina WINCKLER, Giovanni Faria SILVA
Arquivos de Gastroenterologia.2018; 55(3): 274.     CrossRef
Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus
Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub
Antiviral Therapy.2018; 23(1_suppl): 11.     CrossRef